Tyrosine
Tyrosine is a conditionally essential amino acid that serves as a precursor for catecholamine neurotransmitters (dopamine, norepinephrine, epinephrine), thyroid hormones, and melanin pigment synthesis. It has been investigated for cognitive enhancement, stress resilience, and treatment of conditions involving catecholamine depletion such as phenylketonuria and early Parkinson's disease and Alzheimer's disease. As a substrate for melanin production, it is also relevant in melanoma biology and skin pigmentation disorders.
分子量
181.1900 g/mol
LogP
-2.30
TPSA
83.60 Ų
リピンスキーの五則
適合
治療領域
作用機序
Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.
2D構造
Cite this structure
Embed this structure
SMILES
N[C@@H](Cc1ccc(O)cc1)C(=O)O
InChI
InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1
Molecular Formula
C9H11NO3
HBD / HBA
3 / 4
回転可能結合数
3
重原子数
13
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
Tyrosine is a conditionally essential amino acid that serves as a precursor for catecholamine neurotransmitters (dopamine, norepinephrine, epinephrine), thyroid hormones, and melanin pigment synthesis. It has been investigated for cognitive enhancement, stress resilience, and treatment of conditions involving catecholamine depletion such as phenylketonuria and early Parkinson's disease and Alzheimer's disease. As a substrate for melanin production, it is also relevant in melanoma biology and skin pigmentation disorders.
Stimulates melanocyte proliferation and melanin synthesis, increasing photoprotective pigmentation in the skin.
Yes, Tyrosine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL925. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 6057. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tyrosine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tyrosine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tyrosine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tyrosine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tyrosine"></drugfyi-drug>